What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
We compare value-focused dividend growth ETFs to help you spot the best option based on cost, yield, and growth potential.
27,266 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A high-stakes debate is unfolding around SpaceX and its heavy short interest. This article breaks down what it means ...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...
A growing clash over baseball economics enters a new phase as Trump signals support for a hard salary cap in MLB, int...
A veteran tech analyst challenges the AI-rotation selloff, arguing software names are undervalued as rate fears ease ...
Palantir Technologies has delivered a staggering 625% rally since 2020, but a mix of government ties and governance s...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Midweek market noise can derail focus. This Wednesday reads guide cuts through the chatter with clear signals, practi...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
A Dallas Fed study shows a clear split in AI's impact: Gen Z workers face tougher prospects in AI-heavy roles, while ...
A veteran landlord built a 50-property portfolio, then paused growth to chase higher, more scalable income. This arti...